grant

Novel therapies and diagnostic tools in neurogenetic disorders [ 2014 - 2019 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1073323]

Researchers: Dr Eppie Yiu (Principal investigator)

Brief description Friedreich ataxia, a life-shortening neurologic condition, has no proven treatment. This study will assess a medication called resveratrol in 60 individuals in centres in four Australian states. The second study will explore the effectiveness of an emerging imaging technique, high-resolution nerve ultrasound, in the diagnosis and monitoring of conditions that affect the nerves in childhood.

Funding Amount $AUD 190,049.86

Funding Scheme Early Career Fellowships

Notes Health Professional Research ECF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]